Gout & Diet | houstonkidneyclinic.com
Gout is a type of arthritis. It is caused by having too much of the
chemical, uric acid, in your bloodstream
Your diet plays an important role in both causing gout and reducing
the likelihood of suffering further painful attacks of gout.
Gout & Diet | houstonkidneyclinic.com
Gout is a type of arthritis. It is caused by having too much of the
chemical, uric acid, in your bloodstream
Your diet plays an important role in both causing gout and reducing
the likelihood of suffering further painful attacks of gout.
Proper nutrition is an integral part of maintaining healthy bones and preventing falls.
Learn more about Nutrition Services at Burke:
http://www.burke.org/rehab/patientinfo/nutrition-dietician-consult
Proper nutrition is an integral part of maintaining healthy bones and preventing falls.
Learn more about Nutrition Services at Burke:
http://www.burke.org/rehab/patientinfo/nutrition-dietician-consult
Enteric nutrition part 1 ( In Maxillofacial, Head and Neck Surgery )Maxfac Center
An introduction to enteric nutrition and the indications, contraindications, nutritional formulations and various parameters in choosing such formulations.
Mentor: Dr Saikat Saha MDS, OMFS, SIliguri, West Bengal, India
Address: MAXFAC Center for Oral and Maxillofacial and Head & Neck Surgery, Siliguri
Email : maxfacmail@gmail.com
this is a chapter which comes under Nursing Foundations for First year BSc Nursing students. This ppt helps you to learn about the importance of nutrition, BMR, factors influencing dietary intake, factors affecting caloric needs, principles relevant to nutrition, assessment of nutritional status, dysphagia, acute care of patients with nutritional needs, feeding helpless patients, enteral tube feeding, insertion of NG tube, parenteral feeding, medical nutrition therapy, discussion on nursing process.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
1. Enteral and Parenteral Nutrition
Applied Nutrition Unit-IV
Objectives
By the end of this unit the students will be able to:
• Define key terms
• Identify the characteristics, nutritional composition and concentration of formula feedings.
• Discuss complications associated with Enteral feeding.
Definition of Key Terms
• Enteral nutrition: Enteral feeding is a method of giving liquid nutrition directly into the
stomach or jejunum through a tube. (N/G or N/J).
• Parenteral nutrition: formula feed that is given intravenously.
• Infant formula: It is a manufactured food designed and marketed for feeding to babies and
infants under 12 months of age, usually prepared for bottle-feeding or cup-feeding from
powder or liquid. OR
• An artificial substitute for breast milk intended for feeding infants. It can come in powdered
form to be mixed with water or in instant liquid form.
Indications for Tube Feeding
• The following conditions require tube feeding:
• Inability to swallow
• Neurologic and neuromuscular disorders,
• Anatomical and post-surgical malformations of the mouth and esophagus
• Cancer
• Digestive disorders.
• Failure to grow or malnutrition
2. Types of Enteral Feeding Tubes
• According to the American College of Gastroenterology, there are six main types of feeding
tubes. These tubes may have further subtypes depending on exactly where they end in the
stomach or intestines.
• The main types of enteral feeding tubes include:
• Nasogastric tube (NGT) starts in the nose and ends in the stomach.
• Orogastric tube (OGT) starts in the mouth and ends in the stomach.
• Nasoenteric tube starts in the nose and ends in the intestines (subtypes include
nasojejunal and nasoduodenal tubes).
• Oroenteric tubestarts in the mouth and ends in the intestines.
• Gastrostomy tubeis placed through the skin of the abdomen straight to the
stomach (subtypes include PEG, PRG, and button tubes).
• Jejunostomy tubeis placed through the skin of the abdomen straight into the
intestines (subtypes include PEJ and PRJ tubes).
3. Classification of Enteral Formula
Standard (polymeric )
• Formula containing intact nutrition ( protein, fat, and CHO) which require normal or near
normal digestive and absorptive capacity and are complete with respect to vitamin, minerals.
• Contain 1-1.2 kcal/ ml and are used as over the counter oral supplement and tube feeding
formula. protein content 30 – 40 gm/L
Example of Standard Formula
4. Elemental & Semi-Elemental
• Contain partially or completely hydrolyzed nutrient (elemental).
• Formula have been hydrolyzed to contain short chain carbohydrate or simple sugar and amino
acid.
• Elemental formulas are easier for the digestive system to digest and absorb, making them
better suited for adults and children with digestive problems.
• Including malabsorption, short bowel syndrome, inflammatory bowel disease, and other
conditions that can cause problems with absorbing nutrition.
Example of Elemental & Semi- Elemental
5. Disease Specific
• Designed for patients with specific disease states.
• Available for patients with respiratory disease, diabetes, renal failure, hepatic failure, and
immune compromise.
Example of Disease Specific
6. Blenderized Feeding
• Used for patient that cannot tolerate semi- synthetic formulas or who wish to consume family
food.
• Formulize with a mixture of blenderized food source .
• They are made from real food ingredients such as chicken, vegetables and fruit, along with
added vitamins, minerals, fiber and other nutrients.
• Maintenance of aseptic technique is essential to prevent bacterial contamination.
Modular Formula
• Modular: provides protein, fat, or carbohydrate as single nutrients or modular mixtures to
allow adjustment of macronutrient mix.
• Created from individual macronutrient preparations called modules are prepared for patients
who require specific nutrient combination to treat their illness.
Example of Modular Products
7. Complications of Enteral Nutrition
• Food entering the lungs
• Constipation
• Diarrhea
• Improper absorption of nutrients
• Nausea, vomiting
• Dehydration
• Electrolyte abnormalities
• High blood sugar
• Vitamin and mineral deficiencies
• Feeding tubes inserted through the nose, such as nasogastric or nasoenteric tubes, can cause
• Irritation of the nose or throat
• Acute sinus infections
• Ulceration of the larynx or esophagus
• Feeding tubes inserted through the skin of the abdominal wall, such as gastrostomy or
jejunostomy tubes, can become clogged (occluded) or displaced, and wound infections can
occur.
Parenteral Nutrition (Types)
• Delivery of nutrients intravenously, e.g. via the bloodstream.
– Central Parenteral Nutrition:often called Total Parenteral Nutrition
(TPN); delivered into a central vein
– Peripheral Parenteral Nutrition (PPN):delivered into a smaller
or peripheral vein
9. Infant Formula Feeding
• Formula Feeding: Feeding an infant or toddler prepared formula instead of or in addition to
breastfeeding.
• Some parents choose formula-feeding either because of personal preference or because
medical conditions of either the mother or the infant make breastfeeding ill-advised.
Reasons for Choosing Formula-feeding
There is an inadequate supply of maternal breast milk.
The baby is sucking inefficiently.
Parents are unable to quantify the amount of breast milk received by the baby.
Some parents want to know exactly how much their baby is receiving at each feeding, and
formula/bottlefeeding allows exact measurement.
A significant reason for not breastfeeding is concern about transferring certain drugs the
mother is taking through the breast milk to the infant.
10. An increasing number of mothers must return to work shortly after their baby's delivery.
A benefit of bottle-feeding is that the entire
family can immediately become intimately involved in all aspects of the baby’s care, including
feeding.
References
• Enteral nutrition supplies and equipment. https://www.medicare.gov/coverage/enteral-
nutrition-supplies- equipment Accessed April 21, 2020.
• Bankhead R, et al. Enteral Nutrition Practice Recommendations. In: Journal of Parenteral and
Enteral Nutrition. United States. The American Society for Parenteral and Enteral Nutrition;
2009: 122- 167.
• Mesejo A, Acosta JA, Ortega C, et al. Comparison of a high-protein disease-specific enteral
formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin
Nutr,2003;22:295-305.
• Tehila M, Gibstein L, Gordgi D, Cohen JD, Shapira M, Singer P. Enteral fish oil, borage oil and
antioxidants in patients with acute lung injury (ALI). Clin Nutr, 2003;22(S1):S20
Believe you can and you’re halfway there.
Theodore Roosevelt